Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-1388
Full Text
Open PDFAbstract
Available in full text
Date
September 8, 2011
Authors
Publisher
American Association for Cancer Research (AACR)